Patents by Inventor Fernando Noriega

Fernando Noriega has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for Booster Vaccination Against Dengue
    Publication number: 20230338504
    Abstract: The present invention is directed to a method of booster vaccination and to a vaccine composition for use in such a method, for inducing in a human subject a neutralizing antibody response, wherein said subject has previously received a primary vaccination against each of serotypes 1 to 4 of dengue virus and was dengue naïve before said primary vaccination, said composition comprising a dengue antigen of at least one of serotypes 1 to 4 or a nucleic acid construct capable of expressing said antigens in the subject, wherein said booster vaccination results in a 2-fold increase in the neutralizing antibody titre against each of serotypes 1 to 4.
    Type: Application
    Filed: June 2, 2023
    Publication date: October 26, 2023
    Inventors: Diana Coronel, Betzana Zambrano, Fernando Noriega, Tram Anh Wartel
  • Compositions for booster vaccination against dengue
    Patent number: 11690903
    Abstract: The present invention is directed to a method of booster vaccination and to a vaccine composition for use in such a method, for inducing in a human subject a neutralizing antibody response, wherein said subject has previously received a primary vaccination against each of serotypes 1 to 4 of dengue virus and was dengue naïve before said primary vaccination, said composition comprising a dengue antigen of at least one of serotypes 1 to 4 or a nucleic acid construct capable of expressing said antigens in the subject, wherein said booster vaccination results in a 2-fold increase in the neutralizing antibody titre against each of serotypes 1 to 4.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: July 4, 2023
    Assignee: SANOFI PASTEUR
    Inventors: Diana Coronel, Betzana Zambrano, Fernando Noriega, Tram Anh Wartel, Yves Girerd-Chambaz
  • Vaccine compositions against dengue virus diseases
    Patent number: 10946087
    Abstract: The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: March 16, 2021
    Assignee: SANOFI PASTEUR
    Inventors: Nadia Tornieporth, Alain Bouckenooghe, Fernando Noriega, Melanie Saville, Nicholas Jackson, Yves Girerd-Chambaz
  • Concomitant dengue and yellow fever vaccination
    Patent number: 10857222
    Abstract: The present invention relates to a yellow fever (YF) vaccine for use in a method for inducing a protective immune response against yellow fever, wherein said method comprises concomitantly administering said yellow fever vaccine to a human subject together with a tetravalent dengue vaccine which comprises a live attenuated dengue virus of each of serotypes 1 to 4. This invention also pertains to a tetravalent dengue vaccine which comprises a live attenuated dengue virus of each of serotypes 1 to 4 for use in a method of inducing a protective immune response against yellow fever, wherein said method comprises concomitantly administering said tetravalent dengue vaccine to a human subject together with a yellow fever (YF) vaccine.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: December 8, 2020
    Assignee: SANOFI PASTEUR
    Inventors: Fernando Noriega, Betzana Zambrano, Nadia Tornieporth, Mélanie Saville, Eric Plennevaux, Mark Boaz, Thomas Papa
  • Compositions for Booster Vaccination Against Dengue
    Publication number: 20200289637
    Abstract: The present invention is directed to a method of booster vaccination and to a vaccine composition for use in such a method, for inducing in a human subject a neutralizing antibody response, wherein said subject has previously received a primary vaccination against each of serotypes 1 to 4 of dengue virus and was dengue naïve before said primary vaccination, said composition comprising a dengue antigen of at least one of serotypes 1 to 4 or a nucleic acid construct capable of expressing said antigens in the subject, wherein said booster vaccination results in a 2-fold increase in the neutralizing antibody titre against each of serotypes 1 to 4.
    Type: Application
    Filed: October 5, 2018
    Publication date: September 17, 2020
    Inventors: Diana Coronel, Betzana Zambrano, Fernando Noriega, Tram Anh Wartel
  • Concomitant Dengue and Yellow Fever Vaccination
    Publication number: 20180193447
    Abstract: The present invention relates to a yellow fever (YF) vaccine for use in a method for inducing a protective immune response against yellow fever, wherein said method comprises concomitantly administering said yellow fever vaccine to a human subject together with a tetravalent dengue vaccine which comprises a live attenuated dengue virus of each of serotypes 1 to 4. This invention also pertains to a tetravalent dengue vaccine which comprises a live attenuated dengue virus of each of serotypes 1 to 4 for use in a method of inducing a protective immune response against yellow fever, wherein said method comprises concomitantly administering said tetravalent dengue vaccine to a human subject together with a yellow fever (YF) vaccine.
    Type: Application
    Filed: July 1, 2016
    Publication date: July 12, 2018
    Inventors: Fernando Noriega, Betzana Zambrano, Nadia Tornieporth, Mélanie Saville, Eric Plennevaux, Mark Boaz, Thomas Papa
  • VACCINE COMPOSITIONS AGAINST DENGUE VIRUS DISEASES
    Publication number: 20170304426
    Abstract: The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.
    Type: Application
    Filed: September 2, 2015
    Publication date: October 26, 2017
    Applicant: Sanofi Pasteur
    Inventors: Nadia Tornieporth, Alain Bouckenooghe, Fernando Noriega, Melanie Saville, Nicholas Jackson
  • Antibodies having binding specificity to ShET2, an enterotoxin of Shigella flexneri 2A
    Patent number: 5686580
    Abstract: Substantially pure enterotoxins of Shigella flexneri 2a are described, along with a method for obtaining the same, antibodies having binding specificity to the enterotoxins and a method for use of the enterotoxins to develop a non-reactogenic Shigella flexneri 2a vaccine candidate.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 11, 1997
    Assignee: University of Maryland at Baltimore
    Inventors: Alessio Fasano, Myron M. Levine, James P. Nataro, Fernando Noriega
  • Isolated DNA molecule encoding SHET1 of Shigella flexneri 2a and mutant Shigella flexneri 2a
    Patent number: 5589380
    Abstract: Substantially pure enterotoxins of Shigella flexneri 2a are described, along with a method for obtaining the same, antibodies having binding specificity to the enterotoxins and a method for use of the enterotoxins to develop a non-reactogenic Shigella flexneri 2a vaccine candidate.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: December 31, 1996
    Assignee: University of Maryland at Baltimore
    Inventors: Alessio Fasano, Myron M. Levine, James P. Nataro, Fernando Noriega
  • Isolated DNA molecule encoding ShET2 of Shigella flexneri 2a
    Patent number: 5468639
    Abstract: Substantially pure enterotoxins of Shigella flexneri 2a are described, along with a method for obtaining the same, antibodies having binding specificity to the enterotoxins and a method for use of the enterotoxins to develop a non-reactogenic Shigella flexneri 2a vaccine candidate.
    Type: Grant
    Filed: December 2, 1993
    Date of Patent: November 21, 1995
    Assignee: University of Maryland at Baltimore
    Inventors: Alessio Fasano, Myron M. Levine, James P. Nataro, Fernando Noriega